Evofem Biosciences, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Evofem Biosciences, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Evofem Biosciences, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $64K, a 89.5% decline year-over-year.
  • Evofem Biosciences, Inc. annual Operating Lease, Payments for 2023 was $1.52M, a 42.3% decline from 2022.
  • Evofem Biosciences, Inc. annual Operating Lease, Payments for 2022 was $2.64M, a 8.78% increase from 2021.
  • Evofem Biosciences, Inc. annual Operating Lease, Payments for 2021 was $2.43M, a 105% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.52M -$1.12M -42.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $2.64M +$213K +8.78% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $2.43M +$1.24M +105% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-27
2020 $1.19M +$351K +42.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $834K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.